OBI-3424, a Novel AKR1C3-activated Prodrug, Exhibits Potent Efficacy Against Preclinical Models of T-All

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-0551
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Novel PI3K Inhibitor PIK-C98 Displays Potent Preclinical Activity Against Multiple Myeloma

Oncotarget
Oncology
2014English

Bisphosphonamidate Clodronate Prodrug Exhibits Potent Anticancer Activity in Non-Small-Cell Lung Cancer Cells

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2011English

Dual Targeting of Aurora Kinases With AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia With Distinct Post-Mitotic Outcomes

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Sanguinarine Exhibits Potent Efficacy Against Cervical Cancer Cells Through Inhibiting the STAT3 Pathway in Vitro and in Vivo

Cancer Management and Research
Oncology
2019English

Preclinical Toxicity, Toxicokinetics, and Antitumoral Efficacy Studies of DTS-201, a Tumor-Selective Peptidic Prodrug of Doxorubicin

Clinical Cancer Research
Cancer ResearchOncology
2008English

Preclinical Testing of a Novel Personalized Cancer Vaccine for All Solid Tumors and All Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

A Novel Vibriophage Exhibits Inhibitory Activity Against Host Protein Synthesis Machinery

Scientific Reports
Multidisciplinary
2020English

Nanoparticulate Vacuolar ATPase Blocker Exhibits Potent Host-Targeted Antiviral Activity Against Feline Coronavirus

Scientific Reports
Multidisciplinary
2017English

TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy